Infusion Pump Market to Reach US$ 17.7 billion by 2030: Growth Plus Reports

Newark, New Castle, USA, Feb. 03, 2023 (GLOBE NEWSWIRE) — The global infusion pump market is expected to clock at US$ 17.7 billion by 2030. The global infusion pump market is primarily driven by the rising prevalence of chronic diseases such as cancer, arthritis, diabetes, and cardiac diseases. Additionally, the introduction of novel infusion pumps with regulatory approval is fueling the global infusion pump market. Moreover, the increasing adoption of the infusion pump and technological advancement are boosting the growth of the infusion pump market. However, the high cost of the infusion pump and the strict regulatory approval process are holding back the growth of the global infusion pump market.

Request a Sample Copy of the Research Report:

Growth Drivers

The introduction of novel technology is fueling the global infusion pump market. Infusion pump help in releasing drugs systemic and controlled manner to achieve desired therapeutic results. New infusion pumps provide high accuracy of dose, support microdose, and artificial intelligence which helps self-analyses for drug release. In September 2021, new implanted infusion pump technology for type 1 diabetes treatment was acquired by Medtronic. The technology sets itself apart from other implanted pumps by providing MRI compatibility, occlusion detection, and improved insulin delivery precision. The resulting pumps are lighter and smaller than many other insulin pumps on the market right now, despite these advancements.

The global infusion pump market has been analyzed from four different perspectives – Type, Application, End User, and Region.

Excerpts from ‘by Type’

The global infusion pump market based on type has been segmented into:

  • Volumetric Pumps
  • Syringe Pumps
  • Enteral Pumps
  • Insulin Pumps
  • Elastomeric Pumps
  • Implantable Pumps
  • Others

Insulin pumps dominate the global infusion pump market owing to the introduction of the novel insulin pump, technological advancement, and the high presence of key players. Furthermore, it provides superior therapeutic control to insulin pens, high dose accuracy, improved blood glucose monitoring, and effective HbA1c level management, all of which are promoting the growth of the global insulin infusion pump market.

Excerpts From ‘by Application’

The global infusion pump market based on the application has been segmented into:

  • Diabetes
  • Oncology
  • Pain Management
  • Others

Diabetes pumps are dominating the global infusion pump market owing to the rising number of geriatric populations, growing prevalence of type 2 diabetes, growing public awareness of the disease, and more affordable diabetes diagnostics. Additionally, rising government initiatives for diabetes management and increasing insulin pump usage are fueling the global diabetic infusion pump market. The International Diabetes Federation estimates that by 2045, almost 783 million adults will have been diagnosed with diabetes. Oncology infusion pumps are anticipated to experience exceptional growth in the years to come due to an increase in cancer cases and research and development spending on cancer management.

Get your Customized Research Report:

Excerpts from ‘End User’

The global infusion pump market based on end user has been segmented into:

  • Hospitals & Clinics
  • Ambulatory Care
  • Home Care
  • Others

The hospital segment dominates the global infusion pump market owing to the rise in chronic diseases and increased hospital patient traffic for diagnosis and treatment. Additionally, favorable reimbursement policies and rising infusion pump adoption in hospitals are contributing to the growth of the infusion pump market.

Excerpts from ‘by Region Segmentation

The global infusion pump market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The global infusion pump market is dominated by North America, followed by Asia Pacific. The large share of North America in the global market is attributed to the high adoption rate of novel technologies and the rising prevalence of chronic diseases in the region. The North America infusion pump market is also being driven by favorable reimbursement policies, a developed infrastructure, and a high concentration of key players.

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global infusion pump market are:

  • B. Braun Melsungen AG
  • Baxter
  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi AG
  • ICU Medical, Inc.
  • Insulet Corporation
  • Medtronic
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Smith’s Medical
  • Terumo Corporation

Table of Content

    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
    1. Volumetric Pumps
    2. Syringe Pumps
    3. Enteral Pumps
    4. Insulin Pumps
    5. Elastomeric Pumps
    6. Implantable Pumps
    7. Others
    1. Diabetes
    2. Oncology
    3. Pain Management
    4. Others
    1. Hospitals & Clinics
    2. Ambulatory Care
    3. Home Care 
    4. Others


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Buy now complete report here:

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] 256 Chapman Road, STE 105-4, Newark, New Castle - 19702, USA Phone no: +1 888 550 5009 Web:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.